Skip to content
FibonacciAestheticsLog inTry it free

Practice regulations

Annex XVI of the MDR regulation explained for those who use fillers, lasers and aesthetic devices

Annex XVI of the MDR regulation: the six groups of aesthetic products treated as devices, the 2022/2346 common specifications and what to ask your supplier.

The Fibonacci editorial teamUpdated on 9 min read

European Union flags in front of a building
In this article
  1. What Annex XVI is
  2. The six groups
  3. The common specifications: what they require of the manufacturer
  4. Risk classes
  5. The transitional periods
  6. What changes for the doctor who uses the product
  7. How to check a product before buying it

Annex XVI to the European medical devices regulation (MDR, Regulation (EU) 2017/745) is a list of six groups of products that have no medical purpose but that the regulation treats as devices, because they resemble medical devices in the way they work and in their risks. For an aesthetic medicine practice, three groups matter most: facial and cutaneous fillers, devices for reducing adipose tissue, and lasers and high-intensity pulsed light. Since 22 June 2023 these products fall within the regulation.

Below you will find what the list says, what is in and out of it according to the European guidelines, what manufacturers must do, and what you can ask the supplier before buying.

What Annex XVI is

Article 1 of Regulation 2017/745 covers, in addition to medical devices, the groups of products listed in Annex XVI. MDCG guidance 2023-5 recalls the legislator's reasoning: recital 12 says that certain groups of products for which the manufacturer claims only an aesthetic purpose or another non-medical purpose, but which are similar to medical devices in functioning and risk profile, must be covered by the regulation (MDCG 2023-5 (opens in a new tab)). To understand whether a product is in scope, you use the group descriptions in the annex, not the definitions of «medical device».

The six groups

Annex XVI (opens in a new tab) lists:

No.Group (words of the text, summarised)Does it affect the aesthetic practice?
1Contact lenses and other items to be introduced into or onto the eyeUsually no
2Products introduced into the body with invasive surgical instruments to modify anatomy or fix parts of the body (excluding tattoos and piercings)Rarely
3Substances or items intended for facial or cutaneous or mucosal «filling», for subcutaneous, submucosal or intradermal injection (excluding tattoos)Yes: fillers
4Devices for reducing, removing or destroying adipose tissue (liposuction, lipolysis, lipoplasty)Yes, if you use them
5Devices emitting high-intensity electromagnetic radiation (infrared, visible light, ultraviolet), including lasers and pulsed light, for cutaneous photorejuvenation, tattooing, hair removal or other dermal treatmentYes: lasers and pulsed light
6Equipment for brain stimulation with currents or fields that cross the skullNo

What is in and what is out

MDCG guidance 2023-5 provides useful clarifications on the boundary. We report some of them, with the document's words summarised:

  • For group 3, the purpose matters: filling. Mesotherapy products are covered only if their purpose is or includes filling. Pre-filled hyaluronic acid pens and pre-filled dermarollers are examples of «other introduction».
  • Examples of products that are not Annex XVI: serums and creams used after filler, mesotherapy products for biorevitalisation, dermal hydration or fibroblast stimulation, microneedling devices.
  • For group 5, «high intensity» is not defined in the regulation: the guidance refers it to the capacity to produce on the target tissue an effect necessary for the product's purpose. Radiofrequency may be another type of electromagnetic radiation.
  • Among the examples, cold plasma devices and lasers for mucosal rejuvenation remain outside, as do products such as serums or gels to be used before or after hair removal.

These are examples, not an exhaustive list: in case of doubt, the question is for the manufacturer.

The common specifications: what they require of the manufacturer

Implementing Regulation 2022/2346 lays down the common specifications: a general annex (risk management) and one annex for each group. They are not there to tell you what to do in your practice, but they help you understand what you should find on the label and in the instructions.

Fillers (Annex IV).

  • The label bears, in bold and in the largest font size used, the statement that the product is «to be administered exclusively by healthcare professionals appropriately trained, qualified or accredited in accordance with national law», and the indication that it must not be used under 18 years of age.
  • The instructions for use include detailed technical information on administration, the description of the management of the most common side effects (overdose, swelling, induration, nodules, immune responses), the list of components, the recommendation to take into account previous procedures and treatments, and the recommendation to provide for a monitoring period after administration.
  • A plain-language annex, to be given to the patient before treatment, with the residual risks, information on when to contact a healthcare professional and how to report side effects to the manufacturer, and a section to record the site, number and volume of injections. The manufacturer recommends completing it.
  • The manufacturer offers training accessible to users.

Lasers and pulsed light (Annex VI).

  • The instructions state, among other things, minimum and maximum intensity, duration and frequency, pulse energy, fluence, wavelength range, pulse duration, maximum treatment spot size.
  • The manufacturer advises users and consumers to have a medical consultation with diagnostic examination of the skin areas to be treated, except for hair removal when excess hair has no clinical cause, and invites you not to treat a consumer before receiving the documentation of that consultation (point 6.2).
  • For professional-use devices, the instructions include measurement of light energy density and the necessary safety measures at least once a year, and the manufacturer recommends an electrical safety test and maintenance at least once a year (point 6.3).
  • Eye protection supplied with the device and training for users, including on the management of reportable incidents.

Fibonacci has an instrument register with the date of the last maintenance and the next one: it alerts you when a deadline approaches and blocks nothing (instrument register). It is the place to note the deadlines that your device's instructions indicate.

Risk classes

MDCG guidance 2023-5, on the classification rules in Annex VIII to the MDR and on Regulation (EU) 2022/2347, gives examples: permanent dermal fillers are class IIb, resorbable ones and mesotherapy products for filling are class III, and fillers incorporating an anaesthetic or another substance that on its own would be a medicinal product are class III. Laser and pulsed light devices for skin treatment are reclassified as class IIb, and as class IIa if intended for hair removal only. The guidance is addressed to manufacturers and notified bodies: classification is done by the manufacturer. For you it is information to ask the supplier for, not a decision to take.

The transitional periods

Here is the point that explains why different products can coexist in one practice. According to the MDCG questions and answers document (September 2023) (text (opens in a new tab)):

  • the fixed six-month period for applying the new requirements ended on 22 June 2023;
  • for products requiring a notified body, the transitional period lasts until 31 December 2028 (if the manufacturer does not carry out a clinical investigation) or until 31 December 2029 (if it does), under precise conditions: the product was already legally placed on the market in the Union before 22 June 2023, it has not undergone significant changes in design and intended purpose, and, at later dates, the manufacturer has signed a written agreement with a notified body;
  • for products covered by a certificate under the old Directive 93/42/EEC the dates are 31 December 2027 (higher risk) or 31 December 2028 (lower risk);
  • products placed on the market during the transitional period may be made available also after its end (question 12).

The document also says how the manufacturer demonstrates that it falls within the transitional period: with a self-declaration confirming the conditions and indicating the end date, and, when the condition of the agreement with the notified body is triggered, with a confirmation letter from the body. The situation changes over time: always look at the updated version of the documents.

What changes for the doctor who uses the product

The regulation places the heaviest obligations on the manufacturer. For those who use the product, these things emerge from the texts read:

  • CE marking. Devices deemed compliant bear the CE marking, including on instructions for use and packaging, followed where applicable by the notified body number (art. 20 (opens in a new tab)).
  • Label and instructions. They are the document in which to find the required training, minimum age, contraindications, parameters.
  • UDI registration. Article 27 of the regulation and Article 15 of Italian Legislative Decree 137/2022 deal with the unique device identifier: see batch traceability.
  • Incidents. Italian Legislative Decree 137/2022 (art. 10) provides for reporting to the Ministry of serious incidents, including suspected ones, with a medical device: how a vascular occlusion is documented is an example. For application to the products in Annex XVI, check the ministerial decree in force: the legal text speaks of medical devices.
  • The user's obligations are covered in another article and on the European compliance page.

How to check a product before buying it

Questions to ask the supplier, and to keep in writing:

  • Does the product fall within Annex XVI? In which group?
  • Does it bear the CE marking? With a notified body number, where required?
  • Is it under a transitional regime? Until what date? Who confirms this (self-declaration, letter from the body)?
  • Do the label and instructions carry the statements and information of the annex that concerns the product?
  • For a filler: is there the annex to be given to the patient, with the section for site, number and volume?
  • For a device: do the instructions indicate the annual energy measurement and maintenance? Who carries it out?
  • Does the manufacturer offer training?
  • How are complaints and side effects reported to the manufacturer?

The product is then recorded during the session with name, batch and expiry date: this is the subject of what to write in the clinical record after a filler or a toxin. Botulinum toxin does not fall within this list: it is a medicinal product, and the regulation does not apply to medicinal products (Article 1, paragraph 6, point b).

What Fibonacci does for this

This is how it looks in Fibonacci, with sample data:

Sessions with product and batch in Fibonacci, with sample data

Sources

  1. Regulation (EU) 2017/745 (MDR), Article 1 (EUR-Lex) (opens in a new tab)
  2. Regulation (EU) 2017/745 (MDR), Article 20 (EUR-Lex) (opens in a new tab)
  3. Regulation (EU) 2017/745 (MDR), Annex XVI (EUR-Lex) (opens in a new tab)
  4. Commission Implementing Regulation (EU) 2022/2346, Articles 1-3 (EUR-Lex) (opens in a new tab)
  5. Commission Implementing Regulation (EU) 2022/2346, Annexes IV and VI (EUR-Lex) (opens in a new tab)
  6. MDCG 2023-5, Guidance on qualification and classification of Annex XVI products, December 2023 (opens in a new tab)
  7. MDCG, Q&A on transitional provisions for products without an intended medical purpose covered by Annex XVI of the MDR, September 2023 (opens in a new tab)

These articles explain what regulations and guidelines require and what is documented in the medical record. They are not legal or tax advice on your situation and do not say how to treat a patient.

Try Fibonacci in your practice for 15 days, no credit card needed

Within one working day we call you: together we set up your practice and import your data.

Try it free

Read next

All articles